American Journal of Tropical Medicine and Hygiene · 2019 · 43 citations · 35 references
Bloodstream infection surveillance conducted from 2008 to 2014 in all 20 hospitals in Sa Kaeo and Nakhon Phanom provinces, Thailand, allowed us to look at disease burden, antibiotic susceptibilities, and recurrent infections caused by extended-spectrum β-lactamase (ESBL)-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>. Of 97,832 blood specimens, 3,338 were positive for <i>E. coli</i> and 1,086 for <i>K. pneumoniae</i>. The proportion of <i>E. coli</i> isolates producing ESBL significantly increased from 19% to 22% in 2008-2010 to approximately 30% from 2011 to 2014 (<i>P</i>-value for trend = 0.02), whereas ESBL production among <i>K. pneumoniae</i> cases was 27.4% with no significant trend over time. Incidence of community-onset ESBL-producing <i>E. coli</i> increased from 5.4 per 100,000 population in 2008 to 12.8 in 2014, with the highest rates among persons aged ≥ 70 years at 79 cases per 100,000 persons in 2014. From 2008 to 2014, community-onset ESBL-producing <i>K. pneumoniae</i> incidence was 2.7 per 100,000, with a rate of 12.9 among those aged ≥ 70 years. Although most (93.6% of <i>E. coli</i> and 87.6% of <i>K. pneumoniae</i>) infections were community-onset, hospital-onset infections were twice as likely to be ESBL. Population-based surveillance, as described, is vital to accurately monitor emergence and trends in antimicrobial resistance, and in guiding the development of rational antimicrobial therapy recommendations.
35
Mitchell J. Schwaber, Shiri Navon‐Venezia, Keith S. Kaye et al. · Antimicrobial Agents and Chemotherapy · 2006 · 408 citations · Full text
Non-esbl Producers, Esbl-producing Escherichia Coli, Antimicrobial Stewardship +14
Louis B. Rice, Sandra Willey, Genovefa A. Papanicolaou et al. · Antimicrobial Agents and Chemotherapy · 1990 · 382 citations · Full text
Ceftazidime Resistance, Klebsiella Pneumoniae, Antibiotic Resistance +16